UnknownNot Applicable

Clinical Performance of MTA Cavity Lining in the Treatment of Deep Caries Lesions

73 participantsStarted 2015-07-07

Plain-language summary

Aim of this clinical study is to compare the clinical success of two lining materials regarding the maintenance of pulp vitality in the treatment of deep caries lesions over 4- years. A hundred permanent premolar and molars with deep caries lesions without pulp involvement (aged between 18 and 30 years) in 73 patients were randomly divided into the following groups: calcium hydroxide cement (Ca(OH)2) (Dycal, Dentsply/Caulk, Dentsply International Inc, Milford, DE, USA) group and mineral trioxide aggregate (MTA) (Dentsplay, Tulsa Dental, Johnson city, USA) group. Final restoration with a resin-based composite (Gradia Direct Posterior, GC, Tokyo, Japan) in a single session was performed. The following-up period was 6-, 12-, 24-, 36- and 48-months. Two calibrated examiners performed the clinical examination of the pulpal symptoms

Who can participate

Age range18 Years – 30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Primary deep caries lesion with risk of pulp exposure (radiograph depth reaching 3/4 of the dentin).
✓. Restorable by direct restoration and functional permanent posterior teeth,
✓. Positive response to electric pulp testing and negative response to thermal testing.

What they're measuring

Evaluating of clinical success of restorations

Timeframe: 6 months

Trial details

NCT IDNCT04018716

SponsorHacettepe University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-01-07

View on ClinicalTrials.gov More Mineral Trioxide Aggregate trials